Consider the interplay of many complex factors in order to avoid or correct overtreatment in epilepsy

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.9, 2006-09, pp. : 24-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overtreatment in Epilepsy: How It Occurs and How It Can Be Avoided

By Perucca Emilio Kwan Patrick

CNS Drugs, Vol. 19, Iss. 11, 2005-01 ,pp. : 897-908

Adis International

Access to resources Recommend Favorite

Consider age, lifestyle factors only if outcomes influenced

Inpharma, Vol. 1, Iss. 1523, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

COMPLEX INTERPLAY AMONG APOPTOSIS FACTORS: RB, P53, E2F, TGF-beta, CELL CYCLE INHIBITORS AND THE BCL2 GENE FAMILY

By Chiarugi V. Magnelli L. Cinelli M.

Pharmacological Research, Vol. 35, Iss. 4, 1997-04 ,pp. : 257-261

Academic Press

Access to resources Recommend Favorite

Homeostatic bioenergetic network regulation: a novel concept to avoid pharmacoresistance in epilepsy

By Boison Detlev Masino Susan A Geiger Jonathan D

Expert Opinion on Drug Discovery, Vol. 6, Iss. 7, 2011-07 ,pp. : 713-724

Informa Healthcare

Access to resources Recommend Favorite

Consider more than just economic factors in breast cancer care

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 330, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite